A common NKCC2 mutation in Costa Rican Bartter's syndrome patients: evidence for a founder effect

J Am Soc Nephrol. 1997 Nov;8(11):1706-11. doi: 10.1681/ASN.V8111706.

Abstract

Bartter's syndrome involves an overlapping set of closely related renal tubular disorders that can be subdivided into at least three clinical phenotypes: (1) the hypercalciuric antenatal Bartter variant; (2) the classic Bartter variant; and (3) the hypocalciuric-hypomagnesemic Gitelman variant. Recent data demonstrate that in several phenotypically indistinguishable cohorts, antenatal Bartter's syndrome is genetically heterogeneous. In these patients, mutations in the genes encoding either the bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2) or the ATP-regulated potassium channel ROMK (KCNJI) have been identified. A cohort of 20 Costa Rican patients with a congenital syndrome that bears strong similarities to antenatal Bartter's syndrome but also has several distinct features has recently been described. In this cohort, we have identified a predominant mutation that introduces a premature stop in codon W625 of the NKCC2 gene (SCL12A1). This mutant allele is contained on a single common haplotype, suggesting that the majority of antenatal Bartter's syndrome patients in Costa Rica share a single common ancestor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carrier Proteins / genetics*
  • Carrier Proteins / metabolism
  • Child
  • Child, Preschool
  • Cohort Studies
  • Costa Rica
  • DNA / analysis
  • Female
  • Founder Effect*
  • Genotype
  • Humans
  • Kidney Tubules / pathology*
  • Male
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Mutation
  • Pedigree
  • Phenotype
  • Renal Tubular Transport, Inborn Errors / genetics*
  • Sodium-Potassium-Chloride Symporters
  • Syndrome

Substances

  • Carrier Proteins
  • Membrane Proteins
  • Sodium-Potassium-Chloride Symporters
  • DNA